Nicholas Waters
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia.
Journal: The European journal of neuroscience
Published: September 26, 2024
First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Pirepemat, a Cortical Enhancer, in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: March 08, 2021
A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers.
Journal: Pharmacology research & perspectives
Published: November 16, 2020
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) -a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent.
Journal: The Journal of pharmacology and experimental therapeutics
Published: April 02, 2020
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: December 18, 2019
Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington's Disease.
Journal: Journal of Huntington's disease
Published: February 27, 2018
In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery.
Journal: ACS chemical neuroscience
Published: December 21, 2016
Co-administration of the Dopaminergic Stabilizer Pridopidine and Tetrabenazine in Rats.
Journal: Journal of Huntington's disease
Published: October 11, 2014
The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 10, 2014
Systematic in vivo screening of a series of 1-propyl-4-arylpiperidines against dopaminergic and serotonergic properties in rat brain: a scaffold-jumping approach.
Journal: Journal of medicinal chemistry
Published: October 10, 2012
Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines.
Journal: European journal of medicinal chemistry
Published: October 10, 2012
The dopaminergic stabilizer pridopidine decreases expression of L-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model.
Journal: European journal of pharmacology
Published: May 01, 2012
Last Updated: 09/26/2026